Structure-Activity Relationships and Drug Design
Quantitative Aspects of Drug-Receptor Interaction
SBAR II: Application of SBAR
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Dec 20, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Eugene N Muratov1, Jürgen Bajorath2, Robert P Sheridan3
1UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA. alex_tropsha@unc.edu and Department of Pharmaceutical Sciences, Federal University of Paraiba, Joao Pessoa, PB, Brazil.
This correction addresses a previous publication on Quantitative Structure-Activity Relationship (QSAR) modeling. It clarifies details to ensure accuracy in the field of computational chemistry and drug discovery.
05:47In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
Published on: August 28, 2019
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: